Research Article
GABPA Expression in Endometrial Carcinoma: A Prognostic Marker
Table 1
Clinicopathologic characteristics.
| | Characteristic | | (%) |
| | Age (year) | | | | Histology | | | | Endometrioid | 377 | 76.94 | | Serous | 92 | 18.78 | | Mixed serous and endometrioid | 21 | 4.28 | | Grade | | | | G1 | 91 | 18.57 | | G2 | 114 | 23.27 | | G3 | 285 | 58.16 | | Stage | | | | I | 308 | 62.86 | | II | 50 | 10.20 | | III | 109 | 22.25 | | IV | 23 | 4.69 | | Surgical approach | | | | Open | 279 | 56.94 | | Minimally invasive | 189 | 38.57 | | No data | 22 | 4.49 | | Peritoneal cytology | | | | Negative | 325 | 66.33 | | Positive | 47 | 9.59 | | No data | 118 | 24.08 | | Adjuvant therapy | | | | Yes | 299 | 61.02 | | No | 191 | 38.98 | | GABPA expression | | | | Low | 245 | 50.00 | | High | 245 | 50.00 |
|
|
Age: age of endometria carcinoma diagnosis; GABPA: GA-binding protein A.
|